Amanote Research
Register
Sign In
Rethinking Our Approach of Combining Novel Agents With Standard Chemotherapy in Small Cell Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2019.01.021
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
April 1, 2019
Authors
Shun Lu
Ziming Li
Publisher
Elsevier BV
Related search
Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology
Oncology
Chemotherapy in Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Development of Double Cancer in Small Cell Lung Cancer Patients Treated With Intensive Chemotherapy
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Novel Triple‑positive Markers Identified in Human Non‑small Cell Lung Cancer Cell Line With Chemotherapy-Resistant and Putative Cancer Stem Cell Characteristics
Oncology Reports
Medicine
Cancer Research
Oncology
Preoperative Chemotherapy Improves Outcomes in Non-Small Cell Lung Cancer
BMJ
Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer
BMJ
Duration of Chemotherapy in Small Cell Lung Cancer: A Cancer Research Campaign Trial
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Cost Effectiveness of Treatment With New Agents in Advanced Non-Small-Cell Lung Cancer
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
